Advanced Reading List
-
L. Baum, “Sex, Hormones, and Alzheimer’s Disease”, Journal of Gerontology, 2005
- Beral et al, Million Women Study Collaborators, “Breast cancer and hormone-replacement therapy: The Million Women Study”, The Lancet, 10/2003
-
HG Burger, “Androgen production in women”, Fertility and Sterility, 4/2002
- C. Dimitrakakis et al, “Breast cancer incidence in postmenopausal women using testosterone in addition to usual hormone therapy”, Menopause: The Journal of the North American Menopause Society, 2004
- A Elagizi et al, “Testosterone and Cardiovascular Health”, Mayo Clinic Proceedings, 11/2017
- Endogenous Hormones and Prostate Cancer Collaborative Group, “Endogenous sex hormones and prostate cancer: a collaborative analysis of 18 prospective studies”, Journal of the National Cancer Institute, 2/2008
- A Fournier et al, “Unequal risks for breast cancer associated with different hormone replacement therapies: E3N Cohort Study”, British Cancer Research and Treatment, 1/2008
-
E. Friedman, “Hormones are the Answer to Alzheimer’s Disease”, ResearchGate, 11/2018
- Friedman, “The New Testosterone Treatment: How You and Your Doctor Can Fight Breast Cancer, Prostate Cancer, and Alzheimer’s”, 2013
- Gettman, “The Impact of Testosterone Therapy in Men on Cardiovascular Risk: Don’t Be Too Quick to Condemn”, Mayo Clinic Proceedings, 2/2015
- Glaser and C. Dimitrakakis, “Testosterone therapy in women: Myths and Misconceptions”, Maturitas, 2013
- Glaser and C. Dimitrakakis, “Reduced breast cancer incidence in women treated with subcutaneous testosterone, or testosterone with anastrozole: A prospective, observational study”, Maturitas, 2013
- Glaser et al, “Subcutaneous testosterone-letrozole therapy before and concurrent with neoadjuvant breast chemotherapy: clinical response and therapeutic implications”, Menopause: The Journal of the North American Menopause Society, 2017
-
R. Glaser and C. Dimitrakakis, “Testosterone and breast cancer prevention”, Maturitas, 2015
- R. Glaser and C. Dimitrakakis, “Reduced incidence of breast cancer in women adherent to testosterone or testosterone-anastrozole hormone therapy: updated interim analysis”, Maturitas, 2015
- R. Glaser and C. Dimitrakakis, “Rapid response of breast cancer to neoadjuvant intramammary testosterone-anastrozole therapy: neoadjuvant hormone therapy in breast cancer”, Menopause: The Journal of the North American Menopause Society, 2013
- R. Glaser and C. Dimitrakakis, “Testosterone pellet implants and migraine headaches: a pilot study”, Maturitas, 2012
- R. Glaser et al, “Testosterone implants in women: Pharmacological dosing for a physiologic effect”, Maturitas, 2013
- SH Golden et al, “Endogenous postmenopausal hormones and carotid atherosclerosis: a case-control study of the atherosclerosis risk in communities cohort”, American Journal Of Epidemiology, 3/2002
- Haider, “Incidence and severity of prostate cancer (PCa) in 792 hypogonadal men with and without long-term testosterone therapy (TTh): Results from a controlled registry study”, Journal of Clinical Oncology, 2/2018
- VW Henderson et al, “Postmenopausal hormone therapy and Alzheimer’s disease risk: interaction with age”, British Medical Journals, Journal of Neurology, Neurosurgery, and Psychiatry, 2005
- K. Holtorf, “The Bioidentical Debate: Are Bioidentical Hormones (Estradiol, Estriol, and Progesterone) Safer or More Efficacious than Commonly Used Synthetic Versions in Hormone Replacement Therapy?”, Postgraduate Medicine, 1/2009
-
J. Hu and A. Kaplan, “Testosterone Therapy in Men with Prostate Cancer “, European Urology, 12/2015
- F. Iellamo et al, “Testosterone Therapy in Women with Chronic Heart Failure: A Pilot Doubt-blind, Randomized, Placebo-controlled Study”, Journal of The American College of Cardiology, 2010
- R. Whitmer et al, “Timing of Hormone Therapy and Dementia: The Critical Window Therapy Revisited”, Annals of Neurology, 1/2011
-
K. Wylie et al, “Androgens, health, and sexuality in women and men”, Maturitas, 2010
- H. Isbarn et al, “Testosterone and Prostate Cancer: Revisiting Old Paradigms”, European Urology, 2009
- A Khatibi et al, “Could Androgens protect middle-aged women from cardiovascular events? A population-based Study of Swedish women: The Women’s Health in the Lund Area (WHILA) Study”, Climacteric, 2007
- DM Kelly and TH Jones, “Testosterone: a metabolic hormone in health and disease”, Journal of Endocrinology, 2013
- J. Klap et al, “The relationship between total testosterone levels and prostate cancer: a review of the continuing controversy”, Journal of Urology, 2/2015
- M. Mielke et al, “Clinical Epidemiology of Alzheimer’s Disease: assessing sex and gender differences”, Clinical Epidemiology, 2014
-
SD Moffat et al, “Free testosterone and risk for Alzheimer’s Disease in older men”, Neurology, 2004
- A Morgentaler and W. Conners, “Testosterone therapy in men with prostate cancer: literature review, clinical experience, and recommendations”, Asian Journal Of Andrology, 3/2015
- A Morgentaler et al, “Testosterone Therapy and Cardiovascular Risk: Advances and Controversies”, Mayo Clinic Proceedings, 2/2015
- A Morgentaler, “Turning Conventional Wisdom Upside Down”, Cancer, 3/2011
- A Morgentaler, “Rapidly Shifting Concepts Regarding Androgens and Prostate Cancer”, The Scientific World Journal, 2009
- P. Oskui et al, “Testosterone and the Cardiovascular System: A Comprehensive Review of the Clinical Literature”, Journal of the American Heart Association, 2013
- Papasozomenos and A. Shavanas, “Testosterone prevents the heat shock-induced overactivation of glycogen synthase kinase-3B but not of cyclin-dependent kinase 5 and c-Jun NH2-terminal kinase and concomitantly abolishes hyperphosphorylation of T: Implications for Alzheimer’s Disease, Proceedings of the National Academy of Sciences, 2/2002
- Patel and S. Freedland, “New Prostate Cancer Biomarkers: The Search Continues”, European Journal of Urology, 2017
-
The Pituitary Foundation, “Male hormones and infertility issues”, 12/2017
- L. Reinstatler et al, “Robert Benjamin Greenblatt and His Many Pursuits: An Unlikely Founder of the Testosterone Pellet”, Urology, 2014
- C. Pike, “Sex and the development of Alzheimer’s disease”, Journal of Neuroscience Research, 1/2017
- A Ruitenberg et al, “Incidence of dementia: does gender make a difference?”, Neurobiology of Aging, 7/2001
- I San Francisco, “Low free testosterone levels predict disease reclassification in men with prostate cancer undergoing active surveillance”, British Journal of Urology, 2014
- C. Sievers et al, “Low testosterone levels predict all-cause mortality and cardiovascular events in women: a prospective cohort study in German primary care patients”, European Journal of Endocrinology, 2010
-
H. Shao, “Hormone Therapy and Alzheimer’s Disease Dementia”, Neurology, 2012
- AM Traish et al, “Long-Term Testosterone Therapy Improves Cardiometabolic Function and Reduces Risk of Cardiovascular Disease in Men with Hypogonadism: A Real-Life Observational Registry Study Setting Comparing Treated and Untreated (Control) Groups”, Journal of Cardiovascular Pharmacology and Therapeutics, 9/2017
- A Traish and L. Gooren, “Safety of Physiological Testosterone Therapy in Women: Lessons from Female-to-Male Transsexuals (FMT) Treated with Pharmacological Testosterone Therapy”, Journal of Sexual Medicine, 2010
- A Urhausen et al, “Are the cardiac effects of anabolic steroid abuse in strength athletes reversible?”, Heart, 2004
- C. Wallis et al, “Survival and cardiovascular events in men treated with testosterone replacement therapy: an intention-to-treat observational cohort study”, Lancet, 6/2016